Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy

被引:47
作者
Boe, M. G. [1 ]
Salvesen, R. [2 ,3 ]
Mygland, A. [1 ,4 ,5 ]
机构
[1] Sorlandet Hosp, Dept Neurol, Kristiansand, Norway
[2] Nordland Hosp, Dept Neurol, Bodo, Norway
[3] Univ Tromso, Inst Clin Med, Tromso, Norway
[4] Rikshosp Univ Hosp, Hosp Rehabil, Kristiansand, Norway
[5] Univ Bergen, Inst Clin Med, Bergen, Norway
关键词
medication overuse headache; quality of life; sleep; withdrawal; MODIFIABLE RISK-FACTORS; QUALITY-OF-LIFE; TERM FOLLOW-UP; CLINICAL-FEATURES; HOSPITAL ANXIETY; CHRONIC MIGRAINE; DISABILITY; SCALE; AMITRIPTYLINE; DISORDERS;
D O I
10.1111/j.1468-1331.2009.02571.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
We examined prospectively the results of withdrawal therapy in 80 patients with probable medication overuse headache. The aim was to identify baseline patient characteristics that might predict outcome after 1 year (end of study). We classified patients according to results of withdrawal therapy measured as the improvement of headache days (HD) from baseline to end of study. Thirty-six per cent (29/80) had at least 50% improvement. Sixty-four per cent (51/80) had < 50% improvement, and among these, 30% (24/80) had < 10% improvement. The following baseline characteristics were associated with poor outcome of withdrawal therapy: use of codeine-containing drugs, low self-reported sleep quality, and high self-reported bodily pain as measured by the quality of life tool SF-36. Before suggesting withdrawal therapy, one should probably pay more close attention to sleep problems.
引用
收藏
页码:705 / 712
页数:8
相关论文
共 31 条
[1]
Disability in chronic migraine with medication overuse: Treatment effects at 3 years [J].
Andrasik, Frank ;
Grazzi, Licia ;
Usai, Susanna ;
D'Amico, Domenico ;
Kass, Steven ;
Bussone, Gennaro .
HEADACHE, 2007, 47 (09) :1277-1281
[2]
Modifiable risk factors for migraine progression [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
HEADACHE, 2006, 46 (09) :1334-1343
[3]
Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes [J].
Bigal, ME ;
Rapoport, AM ;
Sheftell, FD ;
Tepper, SJ ;
Lipton, RB .
CEPHALALGIA, 2004, 24 (06) :483-490
[4]
Prednisolone does not reduce withdrawal headache -: A randomized, double-blind study [J].
Boe, Magne G. ;
Mygland, Ase ;
Salvesen, Rolf .
NEUROLOGY, 2007, 69 (01) :26-31
[5]
BOE MG, 2009, CEPHALALGIA IN PRESS
[6]
AMITRIPTYLINE IN MIGRAINE PROPHYLAXIS [J].
COUCH, JR ;
HASSANEIN, RS .
ARCHIVES OF NEUROLOGY, 1979, 36 (11) :695-699
[7]
AMITRIPTYLINE IN PROPHYLAXIS OF MIGRAINE [J].
COUCH, JR ;
ZIEGLER, DK ;
HASSANEIN, R .
NEUROLOGY, 1976, 26 (02) :121-127
[8]
Diener H C, 2001, Curr Med Res Opin, V17 Suppl 1, ps17, DOI 10.1185/0300799039117003
[9]
Clinical practice - Chronic daily headache [J].
Dodick, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (02) :158-165
[10]
Drug-induced headache: Long-term follow-up of withdrawal therapy and persistence of drug misuse [J].
Fritsche, G ;
Eberl, A ;
Katsarava, Z ;
Limmroth, V ;
Diener, HC .
EUROPEAN NEUROLOGY, 2001, 45 (04) :229-235